drugset / Trial / NCT02222961
Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of the present study is to obtain information about the safety, tolerability and pharmacokinetics of BIIR 561 after continuous intravenous administration of increasing doses in healthy young volunteers
Timeline
- Start
- 1999-11
- Primary completion
- 2000-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IRAMPANEL | Small molecule | 20 mg | Intravenous |
| Subject | IRAMPANEL | Small molecule | 40 mg | Intravenous |
| Subject | IRAMPANEL | Small molecule | 125 mg | Intravenous |
Indications
No indication recorded.